| From the President's Desk:
The IAS continues to mentor and support the future key opinion leaders in the field through a number of initiatives, especially support of early- and mid-career clinicians and researchers.
The IAS Visiting Fellowship Awards are presented each year in an effort to develop skills that will not only impact favourably on your personal career but will also enhance clinical and research programs in your home country. The deadline to submit your application for 2017 is fast approaching: January 31, 2017. Please visit our web site for more complete information (www.athero.org) but note that you will need confirmation from the host laboratory as part of your application. This program has been in effect since 1991 and has supported more than 85 international scientists working in laboratories around the world, many of whom have gone on to have a major impact on the field.
> Complete Article <
|IAS Visiting Fellowship Opportunities
Application Deadline: January 31, 2017
• 3 - Month Visiting Fellowship Award $5,000
• 6 - Month Visiting Fellowship Award $8,000
For more information click here
IAS Consensus Statement “Defining severe familial hypercholesterolemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel”
The International Atherosclerosis Society (IAS) is proud to announce the publication on the definition of severe FH and the implications for clinical management in The Lancet Diabetes and Endocrinology. The IAS Severe FH Panel, made of 25 internationally renowned experts and chaired by Dr. Raul Santos, worked with the objective of characterizing the severe FH phenotype and made recommendations on how to stratify CVD risk and to whom to prescribe the novel lipid lowering treatments. These recommendations will contribute to improved daily clinical practice and better management of FH patients.
To download the full text, which is open access, please link to and register at the WEBLINK (Published online, May 27, 2016).
For more information about The Lancet, please visit The Lancet Homepage at www.thelancet.com.
Also included in this newsletter:
Circulating Soluble Low-Density Lipoprotein Receptor-Related Protein 1 (sLRP1) Concentration Is Associated with Hypercholesterolemia: A New Potential Biomarker for Atherosclerosis
By: Vicenta Llorente Cortes
Lipid accumulation in the vascular wall is a major problem in atherosclerosis. It has recently been shown that around 40% of foam cells, previously considered of macrophage origin, are of vascular smooth muscle cells (VSMC) origin, indicating that VSMC are crucial players in vascular lipid accumulation. While the incorporation of lipids by macrophages leads to cell death, VSMC-foam cells are more resistant to apoptosis and they may reside in the vessels for years, causing a high impact on the process of vascular degeneration.
> View Complete Commentary <
Childhood Infections, Socio-economic Status, and Adult Cardiometabolic Risk
By: Richard S Liu, David P Burgner, Matthew A Sabin, Costan G Magnussen, Michael Cheung, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Eero Jokinen, Tomi Laitinen, Leena Taittonen, Terence Dwyer, Jorma SA Viikari, Mika Kivimäki, Olli T Raitakari, and Markus Juonala.
There is increasing evidence that childhood infections are associated with increased cardiometabolic risk and disease in later life. It is well-known that cardiometabolic disease shows strong social gradients, but mechanisms are poorly understood. Our recent paper in provides some evidence that childhood infection may lie on the causal pathway linking socioeconomic deprivation in early life and poor adult cardiometabolic health.
> View Complete Commentary <